Hartford Investment Management Co (HIMCO)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.76M Sell
8,140
-261
-3% -$49.9K 0.05% 287
2026
Q1
$1.54M Sell
8,401
-100
-1% -$18.4K 0.05% 310
2025
Q4
$1.5M Sell
8,501
-121
-1% -$19.8K 0.04% 312
2025
Q3
$1.21M Sell
8,622
-169
-2% -$22.8K 0.04% 360
2025
Q2
$1.1M Sell
8,791
-76
-0.9% -$9.47K 0.04% 372
2025
Q1
$1.21M Sell
8,867
-91
-1% -$13K 0.04% 350
2024
Q4
$1.37M Sell
8,958
-174
-2% -$29.3K 0.04% 330
2024
Q3
$1.77M Sell
9,132
-176
-2% -$36.8K 0.06% 290
2024
Q2
$2.16M Sell
9,308
-47
-0.5% -$10.2K 0.07% 246
2024
Q1
$2.02M Sell
9,355
-407
-4% -$95.3K 0.07% 263
2023
Q4
$2.53M Sell
9,762
-2,409
-20% -$592K 0.09% 215
2023
Q3
$3.13M Sell
12,171
-22
-0.2% -$5.88K 0.13% 163
2023
Q2
$3.47M Sell
12,193
-2,029
-14% -$604K 0.13% 154
2023
Q1
$3.95M Sell
14,222
-4,769
-25% -$1.32M 0.13% 158
2022
Q4
$5.26M Sell
18,991
-173
-0.9% -$48.9K 0.16% 123
2022
Q3
$5.12M Buy
19,164
+506
+3% +$107K 0.17% 131
2022
Q2
$3.81M Buy
18,658
+175
+0.9% +$35.8K 0.12% 186
2022
Q1
$3.89M Sell
18,483
-1,062
-5% -$231K 0.1% 204
2021
Q4
$4.69M Buy
19,545
+1,002
+5% +$258K 0.11% 190
2021
Q3
$5.25M Sell
18,543
-1,946
-9% -$638K 0.14% 146
2021
Q2
$7.09M Buy
20,489
+430
+2% +$130K 0.18% 118
2021
Q1
$5.61M Sell
20,059
-354
-2% -$95.5K 0.15% 144
2020
Q4
$5M Buy
20,413
+2,321
+13% +$599K 0.13% 150
2020
Q3
$5.13M Sell
18,092
-1,144
-6% -$319K 0.17% 130
2020
Q2
$5.15M Sell
19,236
-4,062
-17% -$1.22M 0.18% 127
2020
Q1
$7.37M Buy
23,298
+1,730
+8% +$525K 0.25% 94
2019
Q4
$6.4M Sell
21,568
-887
-4% -$246K 0.16% 146
2019
Q3
$5.23M Sell
22,455
-1,747
-7% -$407K 0.15% 167
2019
Q2
$5.66M Sell
24,202
-126
-0.5% -$29.1K 0.16% 157
2019
Q1
$5.75M Sell
24,328
-161
-0.7% -$50.7K 0.16% 149
2018
Q4
$7.37M Buy
24,489
+95
+0.4% +$30.3K 0.23% 94
2018
Q3
$8.62M Sell
24,394
-212
-0.9% -$73K 0.26% 88
2018
Q2
$7.14M Sell
24,606
-16,710
-40% -$4.7M 0.22% 109
2018
Q1
$11.3M Sell
41,316
-3,452
-8% -$1.07M 0.23% 110
2017
Q4
$14.3M Sell
44,768
-1,947
-4% -$625K 0.26% 82
2017
Q3
$14.6M Sell
46,715
-917
-2% -$272K 0.28% 83
2017
Q2
$12.9M Sell
47,632
-2,571
-5% -$680K 0.25% 95
2017
Q1
$13.7M Sell
50,203
-3,388
-6% -$958K 0.26% 88
2016
Q4
$15.2M Sell
53,591
-1,006
-2% -$298K 0.29% 77
2016
Q3
$17.1M Buy
54,597
+878
+2% +$260K 0.34% 62
2016
Q2
$13M Sell
53,719
-1,016
-2% -$268K 0.27% 83
2016
Q1
$14.2M Sell
54,735
-987
-2% -$261K 0.3% 76
2015
Q4
$17.1M Sell
55,722
-5,322
-9% -$1.53M 0.36% 65
2015
Q3
$17.8M Buy
61,044
+31
+0.1% +$10.2K 0.39% 59
2015
Q2
$24.6M Sell
61,013
-4,054
-6% -$1.63M 0.5% 47
2015
Q1
$27.5M Sell
65,067
-3,535
-5% -$1.39M 0.54% 43
2014
Q4
$23.3M Buy
68,602
+7,050
+11% +$2.28M 0.45% 48
2014
Q3
$20.4M Sell
61,552
-1,859
-3% -$613K 0.43% 48
2014
Q2
$20M Sell
63,411
-922
-1% -$277K 0.42% 52
2014
Q1
$19.7M Sell
64,333
-1,441
-2% -$457K 0.41% 52
2013
Q4
$18.4M Sell
65,774
-4,658
-7% -$1.2M 0.38% 56
2013
Q3
$17M Sell
70,432
-2,497
-3% -$559K 0.37% 60
2013
Q2
$15.7M Buy
+72,929
New +$15.6M 0.35% 62

Other funds holding BIIB

Hartford Investment Management Co (HIMCO)'s BIIB Position: Q2 2026 in Review

Hartford Investment Management Co (HIMCO) reduced its Biogen (BIIB) stake by 3.1% in Q2 2026, selling an estimated $49.9K and leaving 8,140 shares worth $1.76M. The position accounts for 0.05% of the portfolio, ranked #287.

Hartford Investment Management Co (HIMCO) first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $27.5M in Q1 2015. 405 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Hartford Investment Management Co (HIMCO) held 8,140 shares of Biogen worth $1.76M as of Q2 2026.
  • Hartford Investment Management Co (HIMCO) sold 261 Biogen shares in Q2 2026, an estimated $49.9K.
  • Biogen made up 0.05% of Hartford Investment Management Co (HIMCO)'s portfolio in Q2 2026, its #287 holding.
  • Hartford Investment Management Co (HIMCO) first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
  • Hartford Investment Management Co (HIMCO)'s Biogen position peaked at $27.5M in Q1 2015.
  • 405 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q2 2026, filed 15 Jul 2026.